Conservative management of COVID-19 associated hypoxaemia
暂无分享,去创建一个
T. Welte | S. Weber-Carstens | C. Criée | W. Windisch | S. Kluge | M. Westhoff | C. Karagiannidis | M. Bachmann
[1] K. Rabe,et al. S2k-Leitlinie – Empfehlungen zur stationären Therapie von Patienten mit COVID-19 , 2021, Pneumologie.
[2] T. Voshaar,et al. Conservative management of COVID-19 associated hypoxaemia , 2021, ERJ Open Research.
[3] M. Sjoding,et al. Racial Bias in Pulse Oximetry Measurement. , 2020, The New England journal of medicine.
[4] M. Tobin,et al. Noninvasive strategies in COVID-19: epistemology, randomised trials, guidelines, physiology , 2020, European Respiratory Journal.
[5] M. Tobin,et al. Hypoxaemia does not necessitate tracheal intubation in COVID-19 patients. Comment on Br J Anaesth 2021; 126: 44-7 , 2020, British Journal of Anaesthesia.
[6] V. Brusasco,et al. Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure , 2020, European Respiratory Journal.
[7] T. Welte,et al. Invasive and Non-Invasive Ventilation in Patients With COVID-19. , 2020, Deutsches Arzteblatt international.
[8] P. Lepper,et al. Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19 , 2020, Respiration.
[9] C. Morélot-Panzini,et al. Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control study , 2020, European Respiratory Journal.